Active — Not RecruitingNot Applicable

Prospective Study for the Evaluation of the Cementless Anatomic Femoral Stem Minimax -Launay

France100 participantsStarted 2019-01-02

Plain-language summary

This is a post-marketing surveillance on MiniMAX Stem

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✕. Patient with local or systemic infection
✕. Participation to biomedical research
✕. Patient whose BMI exceeds 40
✕. Patient with less than 18 years
✕. Protected adults
✕. Vulnerable person according to article L1121-6 of the Code de la Santè Publique.
✕. Pregnant or lactating woman
✕. Patient unable to express his/ her opinion about the participation to the study

Survival Rate

Timeframe: 10 years

NCT IDNCT06012656

SponsorMedacta International SA

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2029-01-02